Paroxysmal Supraventricular Tachycardia Clinical Trial
PSVT is a common rhythm disorder in emergency department which can be recurrent in some
cases.
Intravenous Adenosine is the drug of choice in PSVT control in acute settings but is a very
short acting agent.
Providing a complementary medication to decrease the rate of recurrence of PSVT after its
initial control will be promising.
This study evaluates the role of the oral Verapamil in recurrence control of PSVT in
emergency situations.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04072835 -
Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
|
Phase 3 | |
Completed |
NCT05770921 -
Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia(PSVT)
|
N/A | |
Active, not recruiting |
NCT05820035 -
A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia
|
N/A | |
Not yet recruiting |
NCT06327425 -
MCG for Localization of Tachyarrhythmia's Origin
|
N/A | |
Recruiting |
NCT05410860 -
Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
|
Phase 3 | |
Completed |
NCT03464019 -
Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxymal Supraventricular Tachycardia (PSVT). NODE 301 [Part 1 and Part 2 (RAPID Study)]
|
Phase 3 | |
Completed |
NCT03042078 -
Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia
|
N/A | |
Completed |
NCT04215640 -
Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes
|
N/A | |
Completed |
NCT03348436 -
Study on Left Atrial Function of Paroxysmal Supraventricular Tachycardia After Radiofrequency Ablation
|
N/A | |
Enrolling by invitation |
NCT04952610 -
Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia
|
Phase 3 | |
Recruiting |
NCT05763953 -
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
|
Phase 2 | |
Terminated |
NCT03635996 -
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
|
Phase 3 |